These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
277 related articles for article (PubMed ID: 22942429)
21. The lectin-like domain of thrombomodulin ameliorates diabetic glomerulopathy via complement inhibition. Wang H; Vinnikov I; Shahzad K; Bock F; Ranjan S; Wolter J; Kashif M; Oh J; Bierhaus A; Nawroth P; Kirschfink M; Conway EM; Madhusudhan T; Isermann B Thromb Haemost; 2012 Dec; 108(6):1141-53. PubMed ID: 23014597 [TBL] [Abstract][Full Text] [Related]
22. Pathogenesis of Shiga toxin-induced hemolytic uremic syndrome. Ray PE; Liu XH Pediatr Nephrol; 2001 Oct; 16(10):823-39. PubMed ID: 11605791 [TBL] [Abstract][Full Text] [Related]
23. Decrease of thrombomodulin contributes to the procoagulant state of endothelium in hemolytic uremic syndrome. Fernández GC; Te Loo MW; van der Velden TJ; van der Heuvel LP; Palermo MS; Monnens LL Pediatr Nephrol; 2003 Oct; 18(10):1066-8. PubMed ID: 12920633 [TBL] [Abstract][Full Text] [Related]
24. The lectin like domain of thrombomodulin is involved in the defence against pyelonephritis. Lattenist L; Teske G; Claessen N; Florquin S; Conway EM; Roelofs JJ Thromb Res; 2015 Dec; 136(6):1325-31. PubMed ID: 26573396 [TBL] [Abstract][Full Text] [Related]
25. Hemolytic uremic syndrome induced by lipopolysaccharide and Shiga-like toxin. Ikeda M; Ito S; Honda M Pediatr Nephrol; 2004 May; 19(5):485-9. PubMed ID: 15007712 [TBL] [Abstract][Full Text] [Related]
26. Relevance of neutrophils in the murine model of haemolytic uraemic syndrome: mechanisms involved in Shiga toxin type 2-induced neutrophilia. Fernandez GC; Lopez MF; Gomez SA; Ramos MV; Bentancor LV; Fernandez-Brando RJ; Landoni VI; Dran GI; Meiss R; Isturiz MA; Palermo MS Clin Exp Immunol; 2006 Oct; 146(1):76-84. PubMed ID: 16968401 [TBL] [Abstract][Full Text] [Related]
27. Relative nephroprotection during Escherichia coli O157:H7 infections: association with intravenous volume expansion. Ake JA; Jelacic S; Ciol MA; Watkins SL; Murray KF; Christie DL; Klein EJ; Tarr PI Pediatrics; 2005 Jun; 115(6):e673-80. PubMed ID: 15930195 [TBL] [Abstract][Full Text] [Related]
28. Shiga toxin-mediated disease in MyD88-deficient mice infected with Escherichia coli O157:H7. Calderon Toledo C; Rogers TJ; Svensson M; Tati R; Fischer H; Svanborg C; Karpman D Am J Pathol; 2008 Nov; 173(5):1428-39. PubMed ID: 18832584 [TBL] [Abstract][Full Text] [Related]
29. Shiga toxin promotes podocyte injury in experimental hemolytic uremic syndrome via activation of the alternative pathway of complement. Locatelli M; Buelli S; Pezzotta A; Corna D; Perico L; Tomasoni S; Rottoli D; Rizzo P; Conti D; Thurman JM; Remuzzi G; Zoja C; Morigi M J Am Soc Nephrol; 2014 Aug; 25(8):1786-98. PubMed ID: 24578132 [TBL] [Abstract][Full Text] [Related]
30. Prophylactic heparinization is ineffective in a primate model of hemolytic uremic syndrome. Siegler RL; Pysher TJ; Tesh VL; Denkers ND; Taylor FB Pediatr Nephrol; 2002 Dec; 17(12):1053-8. PubMed ID: 12478357 [TBL] [Abstract][Full Text] [Related]
34. A clinical and bacteriological study of children suffering from haemolytic uraemic syndrome in Tucuman, Argentina. Miceli S; Jure MA; de Saab OA; de Castillo MC; Rojas S; de Holgado AP; de Nader OM Jpn J Infect Dis; 1999 Apr; 52(2):33-7. PubMed ID: 10816611 [TBL] [Abstract][Full Text] [Related]
36. von Willebrand Factor expression in a Shiga toxin-mediated primate model of hemolytic uremic syndrome. Pysher TJ; Siegler RL; Tesh VL; Taylor FB Pediatr Dev Pathol; 2002; 5(5):472-9. PubMed ID: 12196894 [TBL] [Abstract][Full Text] [Related]
37. Depletion of liver and splenic macrophages reduces the lethality of Shiga toxin-2 in a mouse model. Palermo MS; Alves Rosa MF; Van Rooijen N; Isturiz MA Clin Exp Immunol; 1999 Jun; 116(3):462-7. PubMed ID: 10361235 [TBL] [Abstract][Full Text] [Related]
38. Mouse model of hemolytic-uremic syndrome caused by endotoxin-free Shiga toxin 2 (Stx2) and protection from lethal outcome by anti-Stx2 antibody. Sauter KA; Melton-Celsa AR; Larkin K; Troxell ML; O'Brien AD; Magun BE Infect Immun; 2008 Oct; 76(10):4469-78. PubMed ID: 18694970 [TBL] [Abstract][Full Text] [Related]
39. The lectin-like domain of thrombomodulin hampers host defence in pneumococcal pneumonia. Schouten M; de Boer JD; van 't Veer C; Roelofs JJ; Meijers JC; Levi M; Conway EM; van der Poll T Eur Respir J; 2013 Apr; 41(4):935-42. PubMed ID: 22936703 [TBL] [Abstract][Full Text] [Related]